在重症心力衰竭患者减小射出小部分时,对巴罗反射激活疗法进行了为期2年的随访
Sofia Jacinto1, Ana Rita Teixeira1, António Gonçalves1
1Department of Cardiology, Santa Marta Hospital, Unidade Local de Saúde São José, Lisbon, Portugal.
JACC. Case reports
|March 7, 2025
概括
巴罗反射激活疗法 (BAT) 为心力衰竭患者提供了一个有前途的新疗法. 这种治疗改善了两名不适合其他治疗的患者的心脏功能和症状.
科学领域:
- 心脏病学 心脏病学
- 神经调节是一种神经调节.
- 心脏衰竭研究研究
背景情况:
- 巴罗反射激活疗法 (BAT) 是一种新兴的治疗方法,用于症状性心力衰竭与减少喷射率 (HFrEF) 的患者,这些患者没有对最佳医学治疗 (OMT) 作出反应,并且不符合心脏再同步治疗 (CRT) 的条件.
- 通过对大脑动脉回路受体的电刺激来调节自主神经系统,旨在增强心脏功能和缓解症状.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
01:22Heart Failure Drugs: β-Blockers
303
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
303